Repeatable noninvasive measurement of mouse myocardial glucose uptake with 18F-FDG: Evaluation of tracer kinetics in a type 1 diabetes model

Journal of Nuclear Medicine

Volumn 54, Issue 9, 2013, Pages 1637-1644

  Thorn, Stephanie L ^a,b   DeKemp, Robert A ^a   Dumouchel, Tyler ^a   Klein, Ran ^a   Renaud, Jennifer M ^a   Wells, R Glenn ^a   Gollob, Michael H ^b   Beanlands, Rob S ^a,b   DaSilva, Jean N ^a,b  

^a UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Myocardial glucose uptake; Patlak; Positron emission tomography; Streptozotocin; Test retest repeatability

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GLUCOSE; INSULIN; STREPTOZOCIN; TRACER; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CAVA VEIN; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; EX VIVO STUDY; GLUCOSE TRANSPORT; HEART LEFT VENTRICLE; HEART MUSCLE; IMAGE RECONSTRUCTION; INSULIN DEPENDENT DIABETES MELLITUS; MOUSE; NON INVASIVE PROCEDURE; NONHUMAN; NONLINEAR SYSTEM; PRIORITY JOURNAL; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; ANIMAL; HEART; MALE; METABOLIC CLEARANCE RATE; METABOLISM; METHODOLOGY; MYOCARDIAL GLUCOSE UPTAKE; PATLAK; POSITRON EMISSION TOMOGRAPHY; REPRODUCIBILITY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; TEST-RETEST REPEATABILITY;

MYOCARDIAL GLUCOSE UPTAKE; PATLAK; POSITRON EMISSION TOMOGRAPHY; STREPTOZOTOCIN; TEST-RETEST REPEATABILITY;

ANIMALS; DIABETES MELLITUS, TYPE 1; FLUORODEOXYGLUCOSE F18; HEART; MALE; METABOLIC CLEARANCE RATE; MICE; MYOCARDIUM; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84887397275     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.112.110114     Document Type: Article

References (33)

1. Horowitz JD, Chirkov YY, Kennedy JA, Sverdlov AL. Modulation of myocardial metabolism: an emerging therapeutic principle. Curr Opin Cardiol. 2010;25: 329-334.
2. Wang W, Lopaschuk GD. Metabolic therapy for the treatment of ischemic heart disease: reality and expectations. Expert Rev Cardiovasc Ther. 2007;5:1123-1134.
3. Lionetti V, Stanley WC, Recchia FA. Modulating fatty acid oxidation in heart failure. Cardiovasc Res. 2011;90:202-209.
4. Yoshinaga K, Chow BJ, deKemp R, et al. Application of cardiac molecular imaging using positron emission tomography in evaluation of drug and therapeutics for cardiovascular disorders. Curr Pharm Des. 2005;11:903-932.
5. Patlak CS, Blasberg RG, Fenstermacher JD. Graphical evaluation of blood-tobrain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab. 1983;3:1-7.
6. Abraham A, Nichol G, Williams KA, et al. 18F-FDG PET imaging of myocardial viability in an experienced center with access to 18F-FDG and integration with clinical management teams: the Ottawa-FIVE substudy of the PARR 2 trial. J Nucl Med. 2010;51:567-574.
7. Ha AC, Renaud JM, Dekemp RA, et al. In vivo assessment of myocardial glucose uptake by positron emission tomography in adults with the PRKAG2 cardiac syndrome. Circ Cardiovasc Imaging. 2009;2:485-491.
8. Shoghi KI, Finck BN, Schechtman KB, et al. In vivo metabolic phenotyping of myocardial substrate metabolism in rodents: differential efficacy of metformin and rosiglitazone monotherapy. Circ Cardiovasc Imaging. 2009;2:373-381.
9. Shoghi KI, Gropler RJ, Sharp T, et al. Time course of alterations in myocardial glucose utilization in the Zucker diabetic fatty rat with correlation to gene expression of glucose transporters: a small-animal PET investigation. J Nucl Med. 2008;49:1320-1327.
10. Herrero P, Dence CS, Sharp TL, Welch MJ, Gropler RJ. Impact of reversible trapping of tracer and the presence of blood metabolites on measurements of myocardial glucose utilization performed by PET and 18F-fluorodeoxyglucose using the Patlak method. Nucl Med Biol. 2004;31:883-892.
11. Ménard SL, Croteau E, Sarrhini O, et al. Abnormal in vivo myocardial energy substrate uptake in diet-induced type 2 diabetic cardiomyopathy in rats. Am J Physiol Endocrinol Metab. 2010;298:E1049-E1057.
12. Ménard SL, Ci X, Frisch F, et al. Mechanism of reduced myocardial glucose utilization during acute hypertriglyceridemia in rats. Mol Imaging Biol. 2009;11:6-14.
13. Kreissl MC, Stout DB, Wong KP, et al. Influence of dietary state and insulin on myocardial, skeletal muscle and brain [F]-fluorodeoxyglucose kinetics in mice. EJNMMI Res. 2011;1:8.
14. Flores JE, McFarland LM, Vanderbilt A, Ogasawara AK, Williams SP. The effects of anesthetic agent and carrier gas on blood glucose and tissue uptake in mice undergoing dynamic FDG-PET imaging: sevoflurane and isoflurane compared in air and in oxygen. Mol Imaging Biol. 2008;10:192-200.
15. Wong KP, Sha W, Zhang X, Huang SC. Effects of administration route, dietary condition, and blood glucose level on kinetics and uptake of 18F-FDG in mice. J Nucl Med. 2011;52:800-807.
16. Fang YH, Muzic RF Jr. Spillover and partial-volume correction for imagederived input functions for small-animal 18F-FDG PET studies. J Nucl Med. 2008;49:606-614.
17. Ferl GZ, Zhang X, Wu HM, Kreissl MC, Huang SC. Estimation of the 18F-FDG input function in mice by use of dynamic small-animal PET and minimal blood sample data. J Nucl Med. 2007;48:2037-2045.
18. Locke LW, Berr SS, Kundu BK. Image-derived input function from cardiac gated maximum a posteriori reconstructed PET images in mice. Mol Imaging Biol. 2011;13:342-347.
19. Convert L, Morin-Brassard G, Cadorette J, Archambault M, Bentourkia M, Lecomte R. A new tool for molecular imaging: the microvolumetric beta blood counter. J Nucl Med. 2007;48:1197-1206.
20. Tantawy MN, Peterson TE. Simplified [18F]FDG image-derived input function using the left ventricle, liver, and one venous blood sample. Mol Imaging. 2010;9:76-86.
21. Cheng JC, Shoghi K, Laforest R. Quantitative accuracy of MAP reconstruction for dynamic PET imaging in small animals. Med Phys. 2012;39:1029-1041.
22. Sidhu JS, Rajawat YS, Rami TG, et al. Transgenic mouse model of ventricular preexcitation and atrioventricular reentrant tachycardia induced by an AMP-activated protein kinase loss-of-function mutation responsible for Wolff- Parkinson-White syndrome. Circulation. 2005;111:21-29.
23. Rabbani N, Godfrey L, Xue M, et al. Glycation of LDL by methylglyoxal increases arterial atherogenicity: a possible contributor to increased risk of cardiovascular disease in diabetes. Diabetes. 2011;60:1973-1980.
24. Fessler JA, Rogers L. Spatial resolution properties of penalized-likelihood image reconstruction: space invariant tomographs. IEEE Trans Image Process. 1996;5: 1346-1358.
25. Thomas AJ, DaSilva JN, Lortie M, et al. PET of (R)-11C-rolipram binding to phosphodiesterase-4 is reproducible and sensitive to increased norepinephrine in the rat heart. J Nucl Med. 2011;52:263-269.
26. Klein R, Renaud JM, Ziadi MC, et al. Intra- and inter-operator repeatability of myocardial blood flow and myocardial flow reserve measurements using rubidium-82 pet and a highly automated analysis program. J Nucl Cardiol. 2010; 17:600-616.
27. Lamoureux M, Thorn SL, Dumouchel T, et al. Uniformity and reproducibility of normal resting myocardial blood flow in rats with 13N-ammonia and small animal PET. Nucl Med Commun. 2012;33:917-925.
28. Simoẽs MV, Egert S, Ziegler S, et al. Delayed response of insulin-stimulated fluorine-18 deoxyglucose uptake in glucose transporter-4-null mice hearts. J Am Coll Cardiol. 2004;43:1690-1697.
29. Cook GJ, Lodge MA, Marsden PK, Dynes A, Fogelman I. Non-invasive assessment of skeletal kinetics using fluorine-18 fluoride positron emission tomography: evaluation of image and population-derived arterial input functions. Eur J Nucl Med. 1999;26:1424-1429.
30. Anselm DD, Anselm AH, Renaud J, et al. Altered myocardial glucose utilization and the reverse mismatch pattern on rubidium-82 perfusion/F-18-FDG PET during the sub-acute phase following reperfusion of acute anterior myocardial infarction. J Nucl Cardiol. 2011;18:657-667.
31. Birnie D, de Kemp RA, Tang AS, et al. Reduced septal glucose metabolism predicts response to cardiac resynchronization therapy. J Nucl Cardiol. 2012;19:73-83.
32. Mielniczuk LM, Birnie D, Ziadi MC, et al. Relation between right ventricular function and increased right ventricular [18F]fluorodeoxyglucose accumulation in patients with heart failure. Circ Cardiovasc Imaging. 2011;4:59-66.
33. vom Dahl J, Herman WH, Hicks RJ, et al. Myocardial glucose uptake in patients with insulin-dependent diabetes mellitus assessed quantitatively by dynamic positron emission tomography. Circulation. 1993;88:395-404.